select trial semaglutide What the of means for clinicians SELECT trial shows cardiovascular risk

Hieshima, K

Key properties: Does not increase cortisol important for avoiding stress hormone elevation Does not increase prolactin no hormonal disruption Minimal ghrelin-like hunger suitable when appetite stimulation is unwanted Dose-dependent GH release predictable, linear response This selectivity makes Ipamorelin the go-to choice when a clean GH pulse is the primary goal without metabolic side effects

While both men and women can use it for muscle growth, recovery, or recomposition, dosing and cycle length should differ based on body size, hormonal sensitivity, and overall goal

F., Pender, C., Kahn, B

Semaglutide typically achieves around 15% weight loss and liraglutide 58% over 68 weeks in clinical trials